101 related articles for article (PubMed ID: 26105707)
1. Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis.
Edmond MB; Aletraris L; Paino M; Roman PM
Drug Alcohol Depend; 2015 Aug; 153():109-15. PubMed ID: 26105707
[TBL] [Abstract][Full Text] [Related]
2. Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.
Paino M; Aletraris L; Roman PM
Subst Abus; 2015; 36(4):462-9. PubMed ID: 25257691
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
Paino M; Aletraris L; Roman P
J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
[TBL] [Abstract][Full Text] [Related]
4. The United States' Federal Parity Act and treatment of substance use disorders: Administrators' familiarity and perceptions of impact.
Edmond MB; Aletraris L; Roman PM; Fields DL; Bride BE
Int J Drug Policy; 2016 Aug; 34():80-7. PubMed ID: 27450320
[TBL] [Abstract][Full Text] [Related]
5. Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers.
Olmstead TA; Abraham AJ; Martino S; Roman PM
Drug Alcohol Depend; 2012 Jan; 120(1-3):149-54. PubMed ID: 21831536
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of motivational interviewing case management: A latent class analysis of recovery capital among sober living residents with criminal justice involvement.
Witbrodt J; Polcin D; Korcha R; Li L
Drug Alcohol Depend; 2019 Jul; 200():124-132. PubMed ID: 31128464
[TBL] [Abstract][Full Text] [Related]
7. The use of off-label medications in substance abuse treatment programs.
Paino M; Aletraris L; Roman PM
Subst Abus; 2020; 41(3):340-346. PubMed ID: 31361567
[No Abstract] [Full Text] [Related]
8. The treatment effectiveness of outpatient substance misuse treatment organizations between court-mandated and voluntary clients.
Howard DL; McCaughrin WC
Subst Use Misuse; 1996 May; 31(7):895-926. PubMed ID: 8776807
[TBL] [Abstract][Full Text] [Related]
9. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
Wells R; Lemak CH; D'Aunno TA
Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
[TBL] [Abstract][Full Text] [Related]
10. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
Nayar P; Yu F; Apenteng B
Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
[TBL] [Abstract][Full Text] [Related]
11. Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices.
Herbeck DM; Hser YI; Teruya C
Addict Behav; 2008 May; 33(5):699-712. PubMed ID: 18207334
[TBL] [Abstract][Full Text] [Related]
12. The use of art and music therapy in substance abuse treatment programs.
Aletraris L; Paino M; Edmond MB; Roman PM; Bride BE
J Addict Nurs; 2014; 25(4):190-6. PubMed ID: 25514689
[TBL] [Abstract][Full Text] [Related]
13. Service Profiles in Substance Use Disorder Treatment: Are Treatment Facilities Consistent In Service Mix and Service Offerings?
Kelly RJ; Hearld LR
J Stud Alcohol Drugs; 2022 May; 83(3):374-382. PubMed ID: 35590178
[TBL] [Abstract][Full Text] [Related]
14. Patients with substance use and personality disorders: a comparison of patient characteristics, treatment process, and outcomes in Swiss and U.S. substance use disorder programs.
Moggi F; Giovanoli A; Buri C; Moos BS; Moos RH
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):66-72. PubMed ID: 20141400
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Non-Opioid Substance Misusers Among Patients Enrolling in Opioid Treatment Programs: A Latent Class Analysis.
Fong C; Matusow H; Cleland CM; Rosenblum A
J Addict Dis; 2015; 34(2-3):141-50. PubMed ID: 26075932
[TBL] [Abstract][Full Text] [Related]
16. Gender disparity in utilization rates of substance abuse services among female ex-offenders: a population-based analysis.
Mahmood ST; Vaughn MG; Mancini M; Fu QJ
Am J Drug Alcohol Abuse; 2013 Sep; 39(5):332-9. PubMed ID: 23968173
[TBL] [Abstract][Full Text] [Related]
17. Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.
Aletraris L; Bond Edmond M; Roman PM
J Stud Alcohol Drugs; 2015 Jan; 76(1):143-51. PubMed ID: 25486403
[TBL] [Abstract][Full Text] [Related]
18. Implementation of Motivational Interviewing in Substance Use Disorder Treatment: Research Network Participation and Organizational Compatibility.
Rieckmann TR; Abraham AJ; Bride BE
J Addict Med; 2016; 10(6):402-407. PubMed ID: 27559847
[TBL] [Abstract][Full Text] [Related]
19. Patterns of organization and management in private and public substance abuse treatment programs.
Roman PM; Ducharme LJ; Knudsen HK
J Subst Abuse Treat; 2006 Oct; 31(3):235-43. PubMed ID: 16996386
[TBL] [Abstract][Full Text] [Related]
20. Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.
Aletraris L; Roman PM
J Subst Abuse Treat; 2015 Oct; 57():1-8. PubMed ID: 25934459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
